Georg Berding

Georg Berding

Auto-generated profile, based on publicly available information

Georg Berding

Hannover Medical School

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2001 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
GBGeorg Berding
Georg Berding
POPer Odin
Per Odin
DBDavid Brooks
David Brooks
GNGuido Nikkhah
Guido Nikkhah
CMCordula Matthies
Cordula Matthies
WKWolfram H. Knapp
Wolfram H. Knapp

20 June 2014 in BMC Neurology
Verified
Journal Article
Open access
PDF file
FWFlorian Wegner
Florian Wegner
FWFlorian Wilke
Florian Wilke
PRPeter Raab
Peter Raab
STSaid Ben Tayeb
Said Ben Tayeb
ABAnna-Lena Boeck
Anna-Lena Boeck
ENElham Nabavi
Elham Nabavi
Pathogenic autoantibodies targeting the recently identified leucine rich glioma inactivated 1 protein and the subunit 1 of the N-methyl-D-aspartate receptor induce autoimmune encephalitis. A comparison of brain metabolic patterns in 18F-fluoro-2-deoxy-d-glucose positron emission tomography of anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis patients has not been performed yet and shall be helpful in differentiating these two most common forms of autoimmune encephalitis.

1 January 2003 in Nuklearmedizin-Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
TBTh. Brücke
Th. Brücke
POP. Odin
P. Odin
DBD. J. Brooks
D. J. Brooks
HKH. Kolbe
H. Kolbe
PGP. Gielow
P. Gielow
GBG. Berding
G. Berding
Aims: Definition of the regional pattern of dopamine transporter (DAT) dysfunction in advanced Parkinson’s disease (PD) and evaluation of a potential correlation between DAT binding and symptoms; elucidation of the role of DAT imaging in the differential diagnosis of PD and multiple system atrophy (MSA); assessment and comparison of serotonin transporter (SERT) binding in PD and MSA. Methods: [123I]ß-CIT SPECT was performed in 14 patients with advanced PD, 10 with moderate MSA and 20 healthy persons. Specific to nonspecific tracer binding ratios (V3’’) were calculated via ROI analysis of uptake images at 4 h (SERT binding) and 24 h (DAT binding) p. i. Results: In PD bilateral reduction of striatal DAT binding (63-70%) was seen. The caudate ipsilateral to the clinically predominantly affected side showed relatively the least impairment. Significant correlations (r = -0.54 to -0.64) between DAT binding and Hoehn and Yahr stage, UPDRS-scores and duration of disease were found. In MSA DAT binding was less reduced (40-48%) targeting the putamen contralateral to the side of clinical predominance. Significantly lower SERT binding was observed in PD midbrain and MSA hypothalamus compared to controls – and in MSA relative to PD mesial frontal cortex. Conclusions: In advanced PD striatal DAT binding is markedly reduced with the least reduction in caudate ipsilateral to the clinically predominantly affected side. In moderate MSA with asymmetrical symptoms DAT dysfunction is predominant in the contralateral putamen, a pattern seen in early PD. The reduction of SERT in the midbrain area of PD patients suggests additional tegmental degeneration while in MSA the serotonergic system seems to be more generally affected. Ziele: Bestimmung der regionalen Verteilung der Dopamintransporter(DAT)-Dysfunktion bei fortgeschrittenem Morbus Parkinson (MP) und Korrelation der DAT-Bindung zur Symptomatik; Klärung der Bedeutung der DAT-Darstel-lung für die Differenzialdiagnose von MP und Multisystematrophie (MSA); Einschätzung und Vergleich der Serotonintransporter(SERT)-Bindung bei MP und MSA. Methoden: [123I]ß-CIT-SPECT wurde bei 14 Patienten mit fort-geschrittenem MP, 10 mit mittelgradiger MSA und 20 Gesunden durchgeführt. Quotienten von spezifischer zu unspezifischer Bindung des Tracers (V3‘‘) wurden durch ROI-Analysen der Tomogramme nach 4 h (SERT-Bindung) und 24 h (DAT Bindung) p. i. bestimmt. Ergebnisse: Bei MP fanden sich beidseits signifikante Reduktionen (63-70%) der striatalen DAT-Bindung. Im Nucleus caudatus ipsilateral zur klinisch hauptsächlich betroffenen Seite zeigte sich die geringste Minderung. Signifikante Korrelationen (r = -0,54 bis -0,64) zwischen DAT-Bindung und Hoehn-Yahr-Stadium, UPDRS-Score und Erkrankungsdauer wurden beobachtet. Bei MSA war die DAT-Bindung geringer reduziert (um 40-48%) – am deutlichsten im kontralateralen Putamen. Signifikant vermindert war die SERTBindung im Mittelhirn von MP- und Hypothalamus von MSA-Patienten gegenüber Gesunden, sowie im mesialen frontalen Kortex bei MSA im Vergleich zum MP. Schlussfolgerungen: Bei fortgeschrittenem MP ist die DAT Bin-dung im ipsilateral zur klinisch hauptsächlich betroffenen Seite gelegenen Caudatus relativ erhalten und im übrigen Striatum deutlich reduziert. Bei mittelgradiger MSA mit asymmetrischer Symptomatik findet sich wie beim frühen MP die deutlichste DAT-Dysfunktion im kontralateralen Putamen. Die Reduktion der SERT-Bindung im Mittelhirn bei MP lässt auf zusätzliche tegmentale Degeneration schließen, während bei MSA eher das serotonerge System insgesamt betroffen zu sein scheint. * Diese Arbeit ist Prof. Dr. Dr. h.c. Heinz Hundeshagen zum 75. Geburtstag gewidmet.

1 January 2003 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
GBGeorg Berding
Georg Berding
CSChristoph H. Schrader
Christoph H. Schrader
TPThomas Peschel
Thomas Peschel
JHJöRg van Den Hoff
JöRg van Den Hoff
HKHans Kolbe
Hans Kolbe
WKWolfram H. Knapp
Wolfram H. Knapp

5 July 2016 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
CHCathleen Haense
Cathleen Haense
Kirsten Müller-VahlKirsten Müller-Vahl
Kirsten Müller-Vahl
FWFlorian Wilke
Florian Wilke
CSChristoph Schrader
Christoph Schrader
HCHolger H. Capelle
Holger H. Capelle
GBGeorg Berding
Georg Berding
In this study alterations in brain perfusion have been investigated in patients with Tourette syndrome (TS) compared to control subjects. In addition, we investigated the effects of deep brain stimulation (DBS) in both globus pallidus internus (GPi) and centromedian-parafascicular / ventralis oralis internus nuclei of the thalamus (CM/Voi), and sham (SHAM) stimulation on cerebral blood flow. In a prospective controlled, randomized, double-blind setting 5 severely affected adult patients with TS with predominant motor or vocal tics (mean total tic score on the Yale Global Tic Severity Scale: 39) underwent serial brain perfusion single photon emission computed tomography (SPECT) with 99mTc-ECD. Results were compared with data from 6 age-matched control subjects. All patients were investigated at four different time points: once before DBS implantation (preOP) and three times postoperatively. Postoperative scans were performed in a randomized order each after 3 months of either GPi, CM/Voi, or SHAM stimulation. At each investigation, patients were injected at rest while awake, but scanned during anaesthesia. This procedure ensured that neither anaesthesia nor movement artefacts influenced our results. Control subjects were investigated only once at baseline (without DBS or anaesthesia). At baseline, cerebral blood flow was significantly reduced in patients with TS (preOP) compared to controls in the central region, frontal and parietal lobe, specifically in Brodmann areas 1, 4-9, 30, 31, and 40. Significantly increased perfusion was found in the cerebellum. When comparing SHAM stimulation to preOP condition, we found significantly decreased perfusion in basal ganglia and thalamus, but increased perfusion in different parts of the frontal cortex. Compared to SHAM condition both GPi and thalamic stimulation resulted in a significant decrease in cerebral blood flow in basal ganglia and cerebellum, while perfusion in the frontal cortex was significantly increased. Our results provide substantial evidence that in TS brain perfusion is altered in the frontal cortex and the cerebellum and that these changes can be reversed by both: GPi and CM/Voi DBS.

5 June 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GBGeorg Berding
Georg Berding
FWFlorian Wilke
Florian Wilke
TRThilo Rode
Thilo Rode
CHCathleen Haense
Cathleen Haense
GJGert Joseph
Gert Joseph
HLHubert H. Lim
Hubert H. Lim
Considerable progress has been made in the treatment of hearing loss with auditory implants. However, there are still many implanted patients that experience hearing deficiencies, such as limited speech understanding or vanishing perception with continuous stimulation (i.e., abnormal loudness adaptation). The present study aims to identify specific patterns of cerebral cortex activity involved with such deficiencies. We performed O-15-water positron emission tomography (PET) in patients implanted with electrodes within the cochlea, brainstem, or midbrain to investigate the pattern of cortical activation in response to speech or continuous multi-tone stimuli directly inputted into the implant processor that then delivered electrical patterns through those electrodes. Statistical parametric mapping was performed on a single subject basis. Better speech understanding was correlated with a larger extent of bilateral auditory cortex activation. In contrast to speech, the continuous multi-tone stimulus elicited mainly unilateral auditory cortical activity in which greater loudness adaptation corresponded to weaker activation and even deactivation. Interestingly, greater loudness adaptation was correlated with stronger activity within the ventral prefrontal cortex, which could be up-regulated to suppress the irrelevant or aberrant signals into the auditory cortex. The ability to detect these specific cortical patterns and differences across patients and stimuli demonstrates the potential for using PET to diagnose auditory function or dysfunction in implant patients, which in turn could guide the development of appropriate stimulation strategies for improving hearing rehabilitation. Beyond hearing restoration, our study also reveals a potential role of the frontal cortex in suppressing irrelevant or aberrant activity within the auditory cortex, and thus may be relevant for understanding and treating tinnitus.